2025年10月27日,第十届中国医药创新与投资大会“授权与并购论坛”在南京顺利举行。本论坛聚焦当前创新药企全球化进程中最受关注的议题——如何通过授权、并购与资本协同实现价值转化与战略升级。在产业资本回暖、国际合作日益频繁的背景下,授权与并购已成为创新药企从技术驱动走向体系化发展的关键路径。本场论坛由国泰君安海通证券医药联席首席周航主持,论坛邀请来自投资机构、跨国药企、本土Biotech及专业律所...
Source Link2025年10月27日,第十届中国医药创新与投资大会“授权与并购论坛”在南京顺利举行。本论坛聚焦当前创新药企全球化进程中最受关注的议题——如何通过授权、并购与资本协同实现价值转化与战略升级。在产业资本回暖、国际合作日益频繁的背景下,授权与并购已成为创新药企从技术驱动走向体系化发展的关键路径。本场论坛由国泰君安海通证券医药联席首席周航主持,论坛邀请来自投资机构、跨国药企、本土Biotech及专业律所...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.